CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Neem's Hill AB is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Neem's Hill AB
C/O Medicon Village Scheeletorget 1
Phone: +46 102189300p:+46 102189300 223 63  Sweden Ticker: NEEMS BNEEMS B
Business Summary
Neem's Hill AB, previously Scandinavian ChemoTech AB, is a Sweden-based company, which is primarily engaged in the healthcare industry. The Company is focused on cancer treatment and manufactures specialized medical equipment. The Company's key technology is Tumour Specific Electroporation (TSE), which is a cancer-treatment technology platform. The technology is designed to provide an additional treatment option for cancer patients and animals whose tumors may not be suitable for conventional treatment approaches. It's key product are IQwave, a medical device system incorporating the TSE technology for the treatment of solid superficial tumors in human healthcare settings and vetIQure used in the veterinary segment.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202612/31/2025Yes----

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board IngalillForslund Larsson 71 5/8/2019 2/28/2018
Chief Executive Officer, Director Stefan M.Frick 43
Research & Development Director BertilPersson
5 additional Officers and Directors records available in full report.

Business Names
Business Name
CMOTEC B
CMOTECB
NEEMS B

General Information
Number of Employees: 1 (As of 3/31/2026)
Outstanding Shares: 25,453,978 (As of 3/31/2026)
Stock Exchange: STO


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, July 26, 2026